论文部分内容阅读
Genome-wide association studies (GWAS) have successfully identified a substantial number of risk variants for prostate cancer [1-10]. In total, more than 20 single nucleotide polymorphisms (SNPs) that predispose to prostate malignancy have been found scat-tered throughout the genome in coding and non-coding regions.